Liposomes Drug Delivery Market - Global Outlook and Forecast 2022-2028
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
This report contains market size and forecasts of Liposomes Drug Delivery in global, including the following market information:
Global Liposomes Drug Delivery Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Liposomes Drug Delivery Market Sales, 2017-2022, 2023-2028, (K Vials)
Global top five Liposomes Drug Delivery companies in 2021 (%)
The global Liposomes Drug Delivery market was valued at 3431.8 million in 2021 and is projected to reach US$ 6506.7 million by 2028, at a CAGR of 9.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Liposomal Doxorubicin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Liposomes Drug Delivery include Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma, Sigma-Tau Group, Fudan-Zhangjiang, Teva Pharmaceutical and CSPC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Liposomes Drug Delivery manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liposomes Drug Delivery Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Vials)
Global Liposomes Drug Delivery Market Segment Percentages, by Type, 2021 (%)
Global Liposomes Drug Delivery Market Segment Percentages, by Application, 2021 (%)
Global Liposomes Drug Delivery Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Liposomes Drug Delivery revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Liposomes Drug Delivery revenues share in global market, 2021 (%)
Key companies Liposomes Drug Delivery sales in global market, 2017-2022 (Estimated), (K Vials)
Key companies Liposomes Drug Delivery sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
This report contains market size and forecasts of Liposomes Drug Delivery in global, including the following market information:
Global Liposomes Drug Delivery Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Liposomes Drug Delivery Market Sales, 2017-2022, 2023-2028, (K Vials)
Global top five Liposomes Drug Delivery companies in 2021 (%)
The global Liposomes Drug Delivery market was valued at 3431.8 million in 2021 and is projected to reach US$ 6506.7 million by 2028, at a CAGR of 9.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Liposomal Doxorubicin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Liposomes Drug Delivery include Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma, Sigma-Tau Group, Fudan-Zhangjiang, Teva Pharmaceutical and CSPC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Liposomes Drug Delivery manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liposomes Drug Delivery Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Vials)
Global Liposomes Drug Delivery Market Segment Percentages, by Type, 2021 (%)
- Liposomal Doxorubicin
- Liposomal Amphoteracin B
- Liposomal Paclitaxel
- Others
Global Liposomes Drug Delivery Market Segment Percentages, by Application, 2021 (%)
- Fungal Infection Therapy
- Cancer & Tumor Therapy
- Others
Global Liposomes Drug Delivery Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Liposomes Drug Delivery revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Liposomes Drug Delivery revenues share in global market, 2021 (%)
Key companies Liposomes Drug Delivery sales in global market, 2017-2022 (Estimated), (K Vials)
Key companies Liposomes Drug Delivery sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Johnson & Johnson
- Gilead Sciences
- Pacira
- Sun Pharmaceutical
- Luye Pharma
- Sigma-Tau Group
- Fudan-Zhangjiang
- Teva Pharmaceutical
- CSPC
- Novartis
- Kingond Pharm
- Spectrum Pharmaceuticals
- Shanghai New Asia
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Liposomes Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Liposomes Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL LIPOSOMES DRUG DELIVERY OVERALL MARKET SIZE
2.1 Global Liposomes Drug Delivery Market Size: 2021 VS 2028
2.2 Global Liposomes Drug Delivery Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Liposomes Drug Delivery Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Liposomes Drug Delivery Players in Global Market
3.2 Top Global Liposomes Drug Delivery Companies Ranked by Revenue
3.3 Global Liposomes Drug Delivery Revenue by Companies
3.4 Global Liposomes Drug Delivery Sales by Companies
3.5 Global Liposomes Drug Delivery Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Liposomes Drug Delivery Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Liposomes Drug Delivery Product Type
3.8 Tier 1, Tier 2 and Tier 3 Liposomes Drug Delivery Players in Global Market
3.8.1 List of Global Tier 1 Liposomes Drug Delivery Companies
3.8.2 List of Global Tier 2 and Tier 3 Liposomes Drug Delivery Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Liposomes Drug Delivery Market Size Markets, 2021 & 2028
4.1.2 Liposomal Doxorubicin
4.1.3 Liposomal Amphoteracin B
4.1.4 Liposomal Paclitaxel
4.1.5 Others
4.2 By Type - Global Liposomes Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Liposomes Drug Delivery Revenue, 2017-2022
4.2.2 By Type - Global Liposomes Drug Delivery Revenue, 2023-2028
4.2.3 By Type - Global Liposomes Drug Delivery Revenue Market Share, 2017-2028
4.3 By Type - Global Liposomes Drug Delivery Sales & Forecasts
4.3.1 By Type - Global Liposomes Drug Delivery Sales, 2017-2022
4.3.2 By Type - Global Liposomes Drug Delivery Sales, 2023-2028
4.3.3 By Type - Global Liposomes Drug Delivery Sales Market Share, 2017-2028
4.4 By Type - Global Liposomes Drug Delivery Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Liposomes Drug Delivery Market Size, 2021 & 2028
5.1.2 Fungal Infection Therapy
5.1.3 Cancer & Tumor Therapy
5.1.4 Others
5.2 By Application - Global Liposomes Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Liposomes Drug Delivery Revenue, 2017-2022
5.2.2 By Application - Global Liposomes Drug Delivery Revenue, 2023-2028
5.2.3 By Application - Global Liposomes Drug Delivery Revenue Market Share, 2017-2028
5.3 By Application - Global Liposomes Drug Delivery Sales & Forecasts
5.3.1 By Application - Global Liposomes Drug Delivery Sales, 2017-2022
5.3.2 By Application - Global Liposomes Drug Delivery Sales, 2023-2028
5.3.3 By Application - Global Liposomes Drug Delivery Sales Market Share, 2017-2028
5.4 By Application - Global Liposomes Drug Delivery Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Liposomes Drug Delivery Market Size, 2021 & 2028
6.2 By Region - Global Liposomes Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Liposomes Drug Delivery Revenue, 2017-2022
6.2.2 By Region - Global Liposomes Drug Delivery Revenue, 2023-2028
6.2.3 By Region - Global Liposomes Drug Delivery Revenue Market Share, 2017-2028
6.3 By Region - Global Liposomes Drug Delivery Sales & Forecasts
6.3.1 By Region - Global Liposomes Drug Delivery Sales, 2017-2022
6.3.2 By Region - Global Liposomes Drug Delivery Sales, 2023-2028
6.3.3 By Region - Global Liposomes Drug Delivery Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Liposomes Drug Delivery Revenue, 2017-2028
6.4.2 By Country - North America Liposomes Drug Delivery Sales, 2017-2028
6.4.3 US Liposomes Drug Delivery Market Size, 2017-2028
6.4.4 Canada Liposomes Drug Delivery Market Size, 2017-2028
6.4.5 Mexico Liposomes Drug Delivery Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Liposomes Drug Delivery Revenue, 2017-2028
6.5.2 By Country - Europe Liposomes Drug Delivery Sales, 2017-2028
6.5.3 Germany Liposomes Drug Delivery Market Size, 2017-2028
6.5.4 France Liposomes Drug Delivery Market Size, 2017-2028
6.5.5 U.K. Liposomes Drug Delivery Market Size, 2017-2028
6.5.6 Italy Liposomes Drug Delivery Market Size, 2017-2028
6.5.7 Russia Liposomes Drug Delivery Market Size, 2017-2028
6.5.8 Nordic Countries Liposomes Drug Delivery Market Size, 2017-2028
6.5.9 Benelux Liposomes Drug Delivery Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Liposomes Drug Delivery Revenue, 2017-2028
6.6.2 By Region - Asia Liposomes Drug Delivery Sales, 2017-2028
6.6.3 China Liposomes Drug Delivery Market Size, 2017-2028
6.6.4 Japan Liposomes Drug Delivery Market Size, 2017-2028
6.6.5 South Korea Liposomes Drug Delivery Market Size, 2017-2028
6.6.6 Southeast Asia Liposomes Drug Delivery Market Size, 2017-2028
6.6.7 India Liposomes Drug Delivery Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Liposomes Drug Delivery Revenue, 2017-2028
6.7.2 By Country - South America Liposomes Drug Delivery Sales, 2017-2028
6.7.3 Brazil Liposomes Drug Delivery Market Size, 2017-2028
6.7.4 Argentina Liposomes Drug Delivery Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Liposomes Drug Delivery Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Liposomes Drug Delivery Sales, 2017-2028
6.8.3 Turkey Liposomes Drug Delivery Market Size, 2017-2028
6.8.4 Israel Liposomes Drug Delivery Market Size, 2017-2028
6.8.5 Saudi Arabia Liposomes Drug Delivery Market Size, 2017-2028
6.8.6 UAE Liposomes Drug Delivery Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Corporate Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Liposomes Drug Delivery Major Product Offerings
7.1.4 Johnson & Johnson Liposomes Drug Delivery Sales and Revenue in Global (2017-2022)
7.1.5 Johnson & Johnson Key News
7.2 Gilead Sciences
7.2.1 Gilead Sciences Corporate Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences Liposomes Drug Delivery Major Product Offerings
7.2.4 Gilead Sciences Liposomes Drug Delivery Sales and Revenue in Global (2017-2022)
7.2.5 Gilead Sciences Key News
7.3 Pacira
7.3.1 Pacira Corporate Summary
7.3.2 Pacira Business Overview
7.3.3 Pacira Liposomes Drug Delivery Major Product Offerings
7.3.4 Pacira Liposomes Drug Delivery Sales and Revenue in Global (2017-2022)
7.3.5 Pacira Key News
7.4 Sun Pharmaceutical
7.4.1 Sun Pharmaceutical Corporate Summary
7.4.2 Sun Pharmaceutical Business Overview
7.4.3 Sun Pharmaceutical Liposomes Drug Delivery Major Product Offerings
7.4.4 Sun Pharmaceutical Liposomes Drug Delivery Sales and Revenue in Global (2017-2022)
7.4.5 Sun Pharmaceutical Key News
7.5 Luye Pharma
7.5.1 Luye Pharma Corporate Summary
7.5.2 Luye Pharma Business Overview
7.5.3 Luye Pharma Liposomes Drug Delivery Major Product Offerings
7.5.4 Luye Pharma Liposomes Drug Delivery Sales and Revenue in Global (2017-2022)
7.5.5 Luye Pharma Key News
7.6 Sigma-Tau Group
7.6.1 Sigma-Tau Group Corporate Summary
7.6.2 Sigma-Tau Group Business Overview
7.6.3 Sigma-Tau Group Liposomes Drug Delivery Major Product Offerings
7.6.4 Sigma-Tau Group Liposomes Drug Delivery Sales and Revenue in Global (2017-2022)
7.6.5 Sigma-Tau Group Key News
7.7 Fudan-Zhangjiang
7.7.1 Fudan-Zhangjiang Corporate Summary
7.7.2 Fudan-Zhangjiang Business Overview
7.7.3 Fudan-Zhangjiang Liposomes Drug Delivery Major Product Offerings
7.7.4 Fudan-Zhangjiang Liposomes Drug Delivery Sales and Revenue in Global (2017-2022)
7.7.5 Fudan-Zhangjiang Key News
7.8 Teva Pharmaceutical
7.8.1 Teva Pharmaceutical Corporate Summary
7.8.2 Teva Pharmaceutical Business Overview
7.8.3 Teva Pharmaceutical Liposomes Drug Delivery Major Product Offerings
7.8.4 Teva Pharmaceutical Liposomes Drug Delivery Sales and Revenue in Global (2017-2022)
7.8.5 Teva Pharmaceutical Key News
7.9 CSPC
7.9.1 CSPC Corporate Summary
7.9.2 CSPC Business Overview
7.9.3 CSPC Liposomes Drug Delivery Major Product Offerings
7.9.4 CSPC Liposomes Drug Delivery Sales and Revenue in Global (2017-2022)
7.9.5 CSPC Key News
7.10 Novartis
7.10.1 Novartis Corporate Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Liposomes Drug Delivery Major Product Offerings
7.10.4 Novartis Liposomes Drug Delivery Sales and Revenue in Global (2017-2022)
7.10.5 Novartis Key News
7.11 Kingond Pharm
7.11.1 Kingond Pharm Corporate Summary
7.11.2 Kingond Pharm Liposomes Drug Delivery Business Overview
7.11.3 Kingond Pharm Liposomes Drug Delivery Major Product Offerings
7.11.4 Kingond Pharm Liposomes Drug Delivery Sales and Revenue in Global (2017-2022)
7.11.5 Kingond Pharm Key News
7.12 Spectrum Pharmaceuticals
7.12.1 Spectrum Pharmaceuticals Corporate Summary
7.12.2 Spectrum Pharmaceuticals Liposomes Drug Delivery Business Overview
7.12.3 Spectrum Pharmaceuticals Liposomes Drug Delivery Major Product Offerings
7.12.4 Spectrum Pharmaceuticals Liposomes Drug Delivery Sales and Revenue in Global (2017-2022)
7.12.5 Spectrum Pharmaceuticals Key News
7.13 Shanghai New Asia
7.13.1 Shanghai New Asia Corporate Summary
7.13.2 Shanghai New Asia Liposomes Drug Delivery Business Overview
7.13.3 Shanghai New Asia Liposomes Drug Delivery Major Product Offerings
7.13.4 Shanghai New Asia Liposomes Drug Delivery Sales and Revenue in Global (2017-2022)
7.13.5 Shanghai New Asia Key News
8 GLOBAL LIPOSOMES DRUG DELIVERY PRODUCTION CAPACITY, ANALYSIS
8.1 Global Liposomes Drug Delivery Production Capacity, 2017-2028
8.2 Liposomes Drug Delivery Production Capacity of Key Manufacturers in Global Market
8.3 Global Liposomes Drug Delivery Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 LIPOSOMES DRUG DELIVERY SUPPLY CHAIN ANALYSIS
10.1 Liposomes Drug Delivery Industry Value Chain
10.2 Liposomes Drug Delivery Upstream Market
10.3 Liposomes Drug Delivery Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Liposomes Drug Delivery Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Liposomes Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Liposomes Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL LIPOSOMES DRUG DELIVERY OVERALL MARKET SIZE
2.1 Global Liposomes Drug Delivery Market Size: 2021 VS 2028
2.2 Global Liposomes Drug Delivery Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Liposomes Drug Delivery Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Liposomes Drug Delivery Players in Global Market
3.2 Top Global Liposomes Drug Delivery Companies Ranked by Revenue
3.3 Global Liposomes Drug Delivery Revenue by Companies
3.4 Global Liposomes Drug Delivery Sales by Companies
3.5 Global Liposomes Drug Delivery Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Liposomes Drug Delivery Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Liposomes Drug Delivery Product Type
3.8 Tier 1, Tier 2 and Tier 3 Liposomes Drug Delivery Players in Global Market
3.8.1 List of Global Tier 1 Liposomes Drug Delivery Companies
3.8.2 List of Global Tier 2 and Tier 3 Liposomes Drug Delivery Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Liposomes Drug Delivery Market Size Markets, 2021 & 2028
4.1.2 Liposomal Doxorubicin
4.1.3 Liposomal Amphoteracin B
4.1.4 Liposomal Paclitaxel
4.1.5 Others
4.2 By Type - Global Liposomes Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Liposomes Drug Delivery Revenue, 2017-2022
4.2.2 By Type - Global Liposomes Drug Delivery Revenue, 2023-2028
4.2.3 By Type - Global Liposomes Drug Delivery Revenue Market Share, 2017-2028
4.3 By Type - Global Liposomes Drug Delivery Sales & Forecasts
4.3.1 By Type - Global Liposomes Drug Delivery Sales, 2017-2022
4.3.2 By Type - Global Liposomes Drug Delivery Sales, 2023-2028
4.3.3 By Type - Global Liposomes Drug Delivery Sales Market Share, 2017-2028
4.4 By Type - Global Liposomes Drug Delivery Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Liposomes Drug Delivery Market Size, 2021 & 2028
5.1.2 Fungal Infection Therapy
5.1.3 Cancer & Tumor Therapy
5.1.4 Others
5.2 By Application - Global Liposomes Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Liposomes Drug Delivery Revenue, 2017-2022
5.2.2 By Application - Global Liposomes Drug Delivery Revenue, 2023-2028
5.2.3 By Application - Global Liposomes Drug Delivery Revenue Market Share, 2017-2028
5.3 By Application - Global Liposomes Drug Delivery Sales & Forecasts
5.3.1 By Application - Global Liposomes Drug Delivery Sales, 2017-2022
5.3.2 By Application - Global Liposomes Drug Delivery Sales, 2023-2028
5.3.3 By Application - Global Liposomes Drug Delivery Sales Market Share, 2017-2028
5.4 By Application - Global Liposomes Drug Delivery Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Liposomes Drug Delivery Market Size, 2021 & 2028
6.2 By Region - Global Liposomes Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Liposomes Drug Delivery Revenue, 2017-2022
6.2.2 By Region - Global Liposomes Drug Delivery Revenue, 2023-2028
6.2.3 By Region - Global Liposomes Drug Delivery Revenue Market Share, 2017-2028
6.3 By Region - Global Liposomes Drug Delivery Sales & Forecasts
6.3.1 By Region - Global Liposomes Drug Delivery Sales, 2017-2022
6.3.2 By Region - Global Liposomes Drug Delivery Sales, 2023-2028
6.3.3 By Region - Global Liposomes Drug Delivery Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Liposomes Drug Delivery Revenue, 2017-2028
6.4.2 By Country - North America Liposomes Drug Delivery Sales, 2017-2028
6.4.3 US Liposomes Drug Delivery Market Size, 2017-2028
6.4.4 Canada Liposomes Drug Delivery Market Size, 2017-2028
6.4.5 Mexico Liposomes Drug Delivery Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Liposomes Drug Delivery Revenue, 2017-2028
6.5.2 By Country - Europe Liposomes Drug Delivery Sales, 2017-2028
6.5.3 Germany Liposomes Drug Delivery Market Size, 2017-2028
6.5.4 France Liposomes Drug Delivery Market Size, 2017-2028
6.5.5 U.K. Liposomes Drug Delivery Market Size, 2017-2028
6.5.6 Italy Liposomes Drug Delivery Market Size, 2017-2028
6.5.7 Russia Liposomes Drug Delivery Market Size, 2017-2028
6.5.8 Nordic Countries Liposomes Drug Delivery Market Size, 2017-2028
6.5.9 Benelux Liposomes Drug Delivery Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Liposomes Drug Delivery Revenue, 2017-2028
6.6.2 By Region - Asia Liposomes Drug Delivery Sales, 2017-2028
6.6.3 China Liposomes Drug Delivery Market Size, 2017-2028
6.6.4 Japan Liposomes Drug Delivery Market Size, 2017-2028
6.6.5 South Korea Liposomes Drug Delivery Market Size, 2017-2028
6.6.6 Southeast Asia Liposomes Drug Delivery Market Size, 2017-2028
6.6.7 India Liposomes Drug Delivery Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Liposomes Drug Delivery Revenue, 2017-2028
6.7.2 By Country - South America Liposomes Drug Delivery Sales, 2017-2028
6.7.3 Brazil Liposomes Drug Delivery Market Size, 2017-2028
6.7.4 Argentina Liposomes Drug Delivery Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Liposomes Drug Delivery Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Liposomes Drug Delivery Sales, 2017-2028
6.8.3 Turkey Liposomes Drug Delivery Market Size, 2017-2028
6.8.4 Israel Liposomes Drug Delivery Market Size, 2017-2028
6.8.5 Saudi Arabia Liposomes Drug Delivery Market Size, 2017-2028
6.8.6 UAE Liposomes Drug Delivery Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Corporate Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Liposomes Drug Delivery Major Product Offerings
7.1.4 Johnson & Johnson Liposomes Drug Delivery Sales and Revenue in Global (2017-2022)
7.1.5 Johnson & Johnson Key News
7.2 Gilead Sciences
7.2.1 Gilead Sciences Corporate Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences Liposomes Drug Delivery Major Product Offerings
7.2.4 Gilead Sciences Liposomes Drug Delivery Sales and Revenue in Global (2017-2022)
7.2.5 Gilead Sciences Key News
7.3 Pacira
7.3.1 Pacira Corporate Summary
7.3.2 Pacira Business Overview
7.3.3 Pacira Liposomes Drug Delivery Major Product Offerings
7.3.4 Pacira Liposomes Drug Delivery Sales and Revenue in Global (2017-2022)
7.3.5 Pacira Key News
7.4 Sun Pharmaceutical
7.4.1 Sun Pharmaceutical Corporate Summary
7.4.2 Sun Pharmaceutical Business Overview
7.4.3 Sun Pharmaceutical Liposomes Drug Delivery Major Product Offerings
7.4.4 Sun Pharmaceutical Liposomes Drug Delivery Sales and Revenue in Global (2017-2022)
7.4.5 Sun Pharmaceutical Key News
7.5 Luye Pharma
7.5.1 Luye Pharma Corporate Summary
7.5.2 Luye Pharma Business Overview
7.5.3 Luye Pharma Liposomes Drug Delivery Major Product Offerings
7.5.4 Luye Pharma Liposomes Drug Delivery Sales and Revenue in Global (2017-2022)
7.5.5 Luye Pharma Key News
7.6 Sigma-Tau Group
7.6.1 Sigma-Tau Group Corporate Summary
7.6.2 Sigma-Tau Group Business Overview
7.6.3 Sigma-Tau Group Liposomes Drug Delivery Major Product Offerings
7.6.4 Sigma-Tau Group Liposomes Drug Delivery Sales and Revenue in Global (2017-2022)
7.6.5 Sigma-Tau Group Key News
7.7 Fudan-Zhangjiang
7.7.1 Fudan-Zhangjiang Corporate Summary
7.7.2 Fudan-Zhangjiang Business Overview
7.7.3 Fudan-Zhangjiang Liposomes Drug Delivery Major Product Offerings
7.7.4 Fudan-Zhangjiang Liposomes Drug Delivery Sales and Revenue in Global (2017-2022)
7.7.5 Fudan-Zhangjiang Key News
7.8 Teva Pharmaceutical
7.8.1 Teva Pharmaceutical Corporate Summary
7.8.2 Teva Pharmaceutical Business Overview
7.8.3 Teva Pharmaceutical Liposomes Drug Delivery Major Product Offerings
7.8.4 Teva Pharmaceutical Liposomes Drug Delivery Sales and Revenue in Global (2017-2022)
7.8.5 Teva Pharmaceutical Key News
7.9 CSPC
7.9.1 CSPC Corporate Summary
7.9.2 CSPC Business Overview
7.9.3 CSPC Liposomes Drug Delivery Major Product Offerings
7.9.4 CSPC Liposomes Drug Delivery Sales and Revenue in Global (2017-2022)
7.9.5 CSPC Key News
7.10 Novartis
7.10.1 Novartis Corporate Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Liposomes Drug Delivery Major Product Offerings
7.10.4 Novartis Liposomes Drug Delivery Sales and Revenue in Global (2017-2022)
7.10.5 Novartis Key News
7.11 Kingond Pharm
7.11.1 Kingond Pharm Corporate Summary
7.11.2 Kingond Pharm Liposomes Drug Delivery Business Overview
7.11.3 Kingond Pharm Liposomes Drug Delivery Major Product Offerings
7.11.4 Kingond Pharm Liposomes Drug Delivery Sales and Revenue in Global (2017-2022)
7.11.5 Kingond Pharm Key News
7.12 Spectrum Pharmaceuticals
7.12.1 Spectrum Pharmaceuticals Corporate Summary
7.12.2 Spectrum Pharmaceuticals Liposomes Drug Delivery Business Overview
7.12.3 Spectrum Pharmaceuticals Liposomes Drug Delivery Major Product Offerings
7.12.4 Spectrum Pharmaceuticals Liposomes Drug Delivery Sales and Revenue in Global (2017-2022)
7.12.5 Spectrum Pharmaceuticals Key News
7.13 Shanghai New Asia
7.13.1 Shanghai New Asia Corporate Summary
7.13.2 Shanghai New Asia Liposomes Drug Delivery Business Overview
7.13.3 Shanghai New Asia Liposomes Drug Delivery Major Product Offerings
7.13.4 Shanghai New Asia Liposomes Drug Delivery Sales and Revenue in Global (2017-2022)
7.13.5 Shanghai New Asia Key News
8 GLOBAL LIPOSOMES DRUG DELIVERY PRODUCTION CAPACITY, ANALYSIS
8.1 Global Liposomes Drug Delivery Production Capacity, 2017-2028
8.2 Liposomes Drug Delivery Production Capacity of Key Manufacturers in Global Market
8.3 Global Liposomes Drug Delivery Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 LIPOSOMES DRUG DELIVERY SUPPLY CHAIN ANALYSIS
10.1 Liposomes Drug Delivery Industry Value Chain
10.2 Liposomes Drug Delivery Upstream Market
10.3 Liposomes Drug Delivery Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Liposomes Drug Delivery Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Liposomes Drug Delivery in Global Market
Table 2. Top Liposomes Drug Delivery Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Liposomes Drug Delivery Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Liposomes Drug Delivery Revenue Share by Companies, 2017-2022
Table 5. Global Liposomes Drug Delivery Sales by Companies, (K Vials), 2017-2022
Table 6. Global Liposomes Drug Delivery Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Liposomes Drug Delivery Price (2017-2022) & (USD/Vial)
Table 8. Global Manufacturers Liposomes Drug Delivery Product Type
Table 9. List of Global Tier 1 Liposomes Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Liposomes Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Liposomes Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Liposomes Drug Delivery Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Liposomes Drug Delivery Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Liposomes Drug Delivery Sales (K Vials), 2017-2022
Table 15. By Type - Global Liposomes Drug Delivery Sales (K Vials), 2023-2028
Table 16. By Application – Global Liposomes Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Liposomes Drug Delivery Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Liposomes Drug Delivery Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Liposomes Drug Delivery Sales (K Vials), 2017-2022
Table 20. By Application - Global Liposomes Drug Delivery Sales (K Vials), 2023-2028
Table 21. By Region – Global Liposomes Drug Delivery Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Liposomes Drug Delivery Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Liposomes Drug Delivery Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Liposomes Drug Delivery Sales (K Vials), 2017-2022
Table 25. By Region - Global Liposomes Drug Delivery Sales (K Vials), 2023-2028
Table 26. By Country - North America Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Liposomes Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Liposomes Drug Delivery Sales, (K Vials), 2017-2022
Table 29. By Country - North America Liposomes Drug Delivery Sales, (K Vials), 2023-2028
Table 30. By Country - Europe Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Liposomes Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Liposomes Drug Delivery Sales, (K Vials), 2017-2022
Table 33. By Country - Europe Liposomes Drug Delivery Sales, (K Vials), 2023-2028
Table 34. By Region - Asia Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Liposomes Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Liposomes Drug Delivery Sales, (K Vials), 2017-2022
Table 37. By Region - Asia Liposomes Drug Delivery Sales, (K Vials), 2023-2028
Table 38. By Country - South America Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Liposomes Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Liposomes Drug Delivery Sales, (K Vials), 2017-2022
Table 41. By Country - South America Liposomes Drug Delivery Sales, (K Vials), 2023-2028
Table 42. By Country - Middle East & Africa Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Liposomes Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Liposomes Drug Delivery Sales, (K Vials), 2017-2022
Table 45. By Country - Middle East & Africa Liposomes Drug Delivery Sales, (K Vials), 2023-2028
Table 46. Johnson & Johnson Corporate Summary
Table 47. Johnson & Johnson Liposomes Drug Delivery Product Offerings
Table 48. Johnson & Johnson Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 49. Gilead Sciences Corporate Summary
Table 50. Gilead Sciences Liposomes Drug Delivery Product Offerings
Table 51. Gilead Sciences Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 52. Pacira Corporate Summary
Table 53. Pacira Liposomes Drug Delivery Product Offerings
Table 54. Pacira Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 55. Sun Pharmaceutical Corporate Summary
Table 56. Sun Pharmaceutical Liposomes Drug Delivery Product Offerings
Table 57. Sun Pharmaceutical Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 58. Luye Pharma Corporate Summary
Table 59. Luye Pharma Liposomes Drug Delivery Product Offerings
Table 60. Luye Pharma Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 61. Sigma-Tau Group Corporate Summary
Table 62. Sigma-Tau Group Liposomes Drug Delivery Product Offerings
Table 63. Sigma-Tau Group Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 64. Fudan-Zhangjiang Corporate Summary
Table 65. Fudan-Zhangjiang Liposomes Drug Delivery Product Offerings
Table 66. Fudan-Zhangjiang Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 67. Teva Pharmaceutical Corporate Summary
Table 68. Teva Pharmaceutical Liposomes Drug Delivery Product Offerings
Table 69. Teva Pharmaceutical Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 70. CSPC Corporate Summary
Table 71. CSPC Liposomes Drug Delivery Product Offerings
Table 72. CSPC Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 73. Novartis Corporate Summary
Table 74. Novartis Liposomes Drug Delivery Product Offerings
Table 75. Novartis Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 76. Kingond Pharm Corporate Summary
Table 77. Kingond Pharm Liposomes Drug Delivery Product Offerings
Table 78. Kingond Pharm Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 79. Spectrum Pharmaceuticals Corporate Summary
Table 80. Spectrum Pharmaceuticals Liposomes Drug Delivery Product Offerings
Table 81. Spectrum Pharmaceuticals Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 82. Shanghai New Asia Corporate Summary
Table 83. Shanghai New Asia Liposomes Drug Delivery Product Offerings
Table 84. Shanghai New Asia Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 85. Liposomes Drug Delivery Production Capacity (K Vials) of Key Manufacturers in Global Market, 2020-2022 (K Vials)
Table 86. Global Liposomes Drug Delivery Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Liposomes Drug Delivery Production by Region, 2017-2022 (K Vials)
Table 88. Global Liposomes Drug Delivery Production by Region, 2023-2028 (K Vials)
Table 89. Liposomes Drug Delivery Market Opportunities & Trends in Global Market
Table 90. Liposomes Drug Delivery Market Drivers in Global Market
Table 91. Liposomes Drug Delivery Market Restraints in Global Market
Table 92. Liposomes Drug Delivery Raw Materials
Table 93. Liposomes Drug Delivery Raw Materials Suppliers in Global Market
Table 94. Typical Liposomes Drug Delivery Downstream
Table 95. Liposomes Drug Delivery Downstream Clients in Global Market
Table 96. Liposomes Drug Delivery Distributors and Sales Agents in Global Market
Table 1. Key Players of Liposomes Drug Delivery in Global Market
Table 2. Top Liposomes Drug Delivery Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Liposomes Drug Delivery Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Liposomes Drug Delivery Revenue Share by Companies, 2017-2022
Table 5. Global Liposomes Drug Delivery Sales by Companies, (K Vials), 2017-2022
Table 6. Global Liposomes Drug Delivery Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Liposomes Drug Delivery Price (2017-2022) & (USD/Vial)
Table 8. Global Manufacturers Liposomes Drug Delivery Product Type
Table 9. List of Global Tier 1 Liposomes Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Liposomes Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Liposomes Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Liposomes Drug Delivery Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Liposomes Drug Delivery Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Liposomes Drug Delivery Sales (K Vials), 2017-2022
Table 15. By Type - Global Liposomes Drug Delivery Sales (K Vials), 2023-2028
Table 16. By Application – Global Liposomes Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Liposomes Drug Delivery Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Liposomes Drug Delivery Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Liposomes Drug Delivery Sales (K Vials), 2017-2022
Table 20. By Application - Global Liposomes Drug Delivery Sales (K Vials), 2023-2028
Table 21. By Region – Global Liposomes Drug Delivery Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Liposomes Drug Delivery Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Liposomes Drug Delivery Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Liposomes Drug Delivery Sales (K Vials), 2017-2022
Table 25. By Region - Global Liposomes Drug Delivery Sales (K Vials), 2023-2028
Table 26. By Country - North America Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Liposomes Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Liposomes Drug Delivery Sales, (K Vials), 2017-2022
Table 29. By Country - North America Liposomes Drug Delivery Sales, (K Vials), 2023-2028
Table 30. By Country - Europe Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Liposomes Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Liposomes Drug Delivery Sales, (K Vials), 2017-2022
Table 33. By Country - Europe Liposomes Drug Delivery Sales, (K Vials), 2023-2028
Table 34. By Region - Asia Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Liposomes Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Liposomes Drug Delivery Sales, (K Vials), 2017-2022
Table 37. By Region - Asia Liposomes Drug Delivery Sales, (K Vials), 2023-2028
Table 38. By Country - South America Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Liposomes Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Liposomes Drug Delivery Sales, (K Vials), 2017-2022
Table 41. By Country - South America Liposomes Drug Delivery Sales, (K Vials), 2023-2028
Table 42. By Country - Middle East & Africa Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Liposomes Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Liposomes Drug Delivery Sales, (K Vials), 2017-2022
Table 45. By Country - Middle East & Africa Liposomes Drug Delivery Sales, (K Vials), 2023-2028
Table 46. Johnson & Johnson Corporate Summary
Table 47. Johnson & Johnson Liposomes Drug Delivery Product Offerings
Table 48. Johnson & Johnson Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 49. Gilead Sciences Corporate Summary
Table 50. Gilead Sciences Liposomes Drug Delivery Product Offerings
Table 51. Gilead Sciences Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 52. Pacira Corporate Summary
Table 53. Pacira Liposomes Drug Delivery Product Offerings
Table 54. Pacira Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 55. Sun Pharmaceutical Corporate Summary
Table 56. Sun Pharmaceutical Liposomes Drug Delivery Product Offerings
Table 57. Sun Pharmaceutical Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 58. Luye Pharma Corporate Summary
Table 59. Luye Pharma Liposomes Drug Delivery Product Offerings
Table 60. Luye Pharma Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 61. Sigma-Tau Group Corporate Summary
Table 62. Sigma-Tau Group Liposomes Drug Delivery Product Offerings
Table 63. Sigma-Tau Group Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 64. Fudan-Zhangjiang Corporate Summary
Table 65. Fudan-Zhangjiang Liposomes Drug Delivery Product Offerings
Table 66. Fudan-Zhangjiang Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 67. Teva Pharmaceutical Corporate Summary
Table 68. Teva Pharmaceutical Liposomes Drug Delivery Product Offerings
Table 69. Teva Pharmaceutical Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 70. CSPC Corporate Summary
Table 71. CSPC Liposomes Drug Delivery Product Offerings
Table 72. CSPC Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 73. Novartis Corporate Summary
Table 74. Novartis Liposomes Drug Delivery Product Offerings
Table 75. Novartis Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 76. Kingond Pharm Corporate Summary
Table 77. Kingond Pharm Liposomes Drug Delivery Product Offerings
Table 78. Kingond Pharm Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 79. Spectrum Pharmaceuticals Corporate Summary
Table 80. Spectrum Pharmaceuticals Liposomes Drug Delivery Product Offerings
Table 81. Spectrum Pharmaceuticals Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 82. Shanghai New Asia Corporate Summary
Table 83. Shanghai New Asia Liposomes Drug Delivery Product Offerings
Table 84. Shanghai New Asia Liposomes Drug Delivery Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 85. Liposomes Drug Delivery Production Capacity (K Vials) of Key Manufacturers in Global Market, 2020-2022 (K Vials)
Table 86. Global Liposomes Drug Delivery Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Liposomes Drug Delivery Production by Region, 2017-2022 (K Vials)
Table 88. Global Liposomes Drug Delivery Production by Region, 2023-2028 (K Vials)
Table 89. Liposomes Drug Delivery Market Opportunities & Trends in Global Market
Table 90. Liposomes Drug Delivery Market Drivers in Global Market
Table 91. Liposomes Drug Delivery Market Restraints in Global Market
Table 92. Liposomes Drug Delivery Raw Materials
Table 93. Liposomes Drug Delivery Raw Materials Suppliers in Global Market
Table 94. Typical Liposomes Drug Delivery Downstream
Table 95. Liposomes Drug Delivery Downstream Clients in Global Market
Table 96. Liposomes Drug Delivery Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Liposomes Drug Delivery Segment by Type
Figure 2. Liposomes Drug Delivery Segment by Application
Figure 3. Global Liposomes Drug Delivery Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Liposomes Drug Delivery Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Liposomes Drug Delivery Revenue, 2017-2028 (US$, Mn)
Figure 7. Liposomes Drug Delivery Sales in Global Market: 2017-2028 (K Vials)
Figure 8. The Top 3 and 5 Players Market Share by Liposomes Drug Delivery Revenue in 2021
Figure 9. By Type - Global Liposomes Drug Delivery Sales Market Share, 2017-2028
Figure 10. By Type - Global Liposomes Drug Delivery Revenue Market Share, 2017-2028
Figure 11. By Type - Global Liposomes Drug Delivery Price (USD/Vial), 2017-2028
Figure 12. By Application - Global Liposomes Drug Delivery Sales Market Share, 2017-2028
Figure 13. By Application - Global Liposomes Drug Delivery Revenue Market Share, 2017-2028
Figure 14. By Application - Global Liposomes Drug Delivery Price (USD/Vial), 2017-2028
Figure 15. By Region - Global Liposomes Drug Delivery Sales Market Share, 2017-2028
Figure 16. By Region - Global Liposomes Drug Delivery Revenue Market Share, 2017-2028
Figure 17. By Country - North America Liposomes Drug Delivery Revenue Market Share, 2017-2028
Figure 18. By Country - North America Liposomes Drug Delivery Sales Market Share, 2017-2028
Figure 19. US Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Liposomes Drug Delivery Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Liposomes Drug Delivery Sales Market Share, 2017-2028
Figure 24. Germany Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 25. France Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Liposomes Drug Delivery Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Liposomes Drug Delivery Sales Market Share, 2017-2028
Figure 33. China Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 37. India Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Liposomes Drug Delivery Revenue Market Share, 2017-2028
Figure 39. By Country - South America Liposomes Drug Delivery Sales Market Share, 2017-2028
Figure 40. Brazil Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Liposomes Drug Delivery Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Liposomes Drug Delivery Sales Market Share, 2017-2028
Figure 44. Turkey Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 48. Global Liposomes Drug Delivery Production Capacity (K Vials), 2017-2028
Figure 49. The Percentage of Production Liposomes Drug Delivery by Region, 2020 VS 2027
Figure 50. Liposomes Drug Delivery Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Liposomes Drug Delivery Segment by Type
Figure 2. Liposomes Drug Delivery Segment by Application
Figure 3. Global Liposomes Drug Delivery Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Liposomes Drug Delivery Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Liposomes Drug Delivery Revenue, 2017-2028 (US$, Mn)
Figure 7. Liposomes Drug Delivery Sales in Global Market: 2017-2028 (K Vials)
Figure 8. The Top 3 and 5 Players Market Share by Liposomes Drug Delivery Revenue in 2021
Figure 9. By Type - Global Liposomes Drug Delivery Sales Market Share, 2017-2028
Figure 10. By Type - Global Liposomes Drug Delivery Revenue Market Share, 2017-2028
Figure 11. By Type - Global Liposomes Drug Delivery Price (USD/Vial), 2017-2028
Figure 12. By Application - Global Liposomes Drug Delivery Sales Market Share, 2017-2028
Figure 13. By Application - Global Liposomes Drug Delivery Revenue Market Share, 2017-2028
Figure 14. By Application - Global Liposomes Drug Delivery Price (USD/Vial), 2017-2028
Figure 15. By Region - Global Liposomes Drug Delivery Sales Market Share, 2017-2028
Figure 16. By Region - Global Liposomes Drug Delivery Revenue Market Share, 2017-2028
Figure 17. By Country - North America Liposomes Drug Delivery Revenue Market Share, 2017-2028
Figure 18. By Country - North America Liposomes Drug Delivery Sales Market Share, 2017-2028
Figure 19. US Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Liposomes Drug Delivery Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Liposomes Drug Delivery Sales Market Share, 2017-2028
Figure 24. Germany Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 25. France Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Liposomes Drug Delivery Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Liposomes Drug Delivery Sales Market Share, 2017-2028
Figure 33. China Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 37. India Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Liposomes Drug Delivery Revenue Market Share, 2017-2028
Figure 39. By Country - South America Liposomes Drug Delivery Sales Market Share, 2017-2028
Figure 40. Brazil Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Liposomes Drug Delivery Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Liposomes Drug Delivery Sales Market Share, 2017-2028
Figure 44. Turkey Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Liposomes Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 48. Global Liposomes Drug Delivery Production Capacity (K Vials), 2017-2028
Figure 49. The Percentage of Production Liposomes Drug Delivery by Region, 2020 VS 2027
Figure 50. Liposomes Drug Delivery Industry Value Chain
Figure 51. Marketing Channels
